This session will be a review of common conundrums that are faced by hepatologists. We will hear from experts in the field to hear their management of choice for difficult circumstances.

Artificial Intelligence (AI) technology has revolutionized the way we process, analyze, and interpret complex data in liver research and clinical practice. One of the most promising AI applications is the use of chatbots such as ChatGPT and Midjourney, wh

Implementation Considerations for Expanding Access to Treatment in Different Regions

The goal of this event is to provide an opportunity for leading-edge basic and clinical scientists to engage and interact with the audience on recent advancements in DILI.
The idea is loosely based on NPR’s weekend game show “Wait, Wait, Don’t Tell Me”.

¡Ya no más EHGNA! En nuestra lengua Esteatosis Hepatica es el nuevo término general. Y se crea la nueva nomenclatura Esteatosis Hepática Metabólica (MASLD).  

Memorial Sloan Kettering Cancer Center

90 minute: Talks + Panel Discussion

This session delves into the progress in diagnosing At-Risk-MASH, with discussions on the viability of achieving MASH resolution through drug development and the potential of non-invasive tests (NITs) for outcome prediction. The session also explores a Ph

University of California, San Francisco